Piotas

[NIOME @NiomeAI]

Join us for our weekly Space to hear what’s next and get a closer look at our plans for the future.🧬

Conviction, Migration, and Pulse Season 2.🚀

https://t.co/Tm7fZ5sURC

[NIOME @NiomeAI]

The future of synthetic biology depends on more than innovation, it requires responsibility.‼️

As biosafety, biosecurity, and governance challenges grow alongside scientific advances, new approaches to oversight are needed.🩺

NIOME investigates how transparency and decentralized models can strengthen innovation in science.🧬

[NIOME @NiomeAI]

We've been renewed for Season 2!🎉

Season 1 was just the beginning.🚀

Our next season will dive deeper into the forces shaping our future, exploring the intersection of AI, emerging technologies, science and education.📚

Join us as we uncover new innovations, challenge perspectives, and discuss what comes next in a rapidly evolving world.🌍

Stay tuned. The next chapter of Pulse is here.‼️

[NIOME @NiomeAI]

The future of medicine isn't one-size-fits-all — it's built around you.💪

NIOME is helping make that future possible by using decentralized AI and synthetic genomic data to unlock powerful health insights without compromising privacy.🧬

Smarter research, more precise treatments, and a faster path to personalized healthcare? 💊

That's the NIOME vision!‼️

https://t.co/FxL6Xj6HBK

[Tao Outsider @TaoOutsider]

Grayscale just decided to take a position on bittensor:native Bittensor.

The thesis is simple: Centralized AI is vulnerable to governments, institutions, restrictions, and censorship.

Decentralized AI offers an alternative.

Last week, it became a practical one.

Bittensor was built for a world where intelligence can remain open, permissionless, and globally distributed.

Grayscale seems to understand that.

The market is starting to understand it too.

[NIOME @NiomeAI]

What happens when AI makes the wrong decision?⚠️

Without ethical safeguards, AI systems can reinforce bias, compromise privacy, and make decisions that affect people's lives unfairly. 💔

That's why ethics is at the heart of NIOME. 💪

By combining decentralised AI with synthetic human genomes, we'll give you access to scalable data while supporting transparent, private, and ethical research. 🧬

Discover why ethics is essential for building AI in today's poster or check out NIOME: https://t.co/Vmho9gxN1T

[NIOME @NiomeAI]

New Episode of 'Pulse'🎙️
The Role of AI in Human Longevity

AI is no longer just a promise. It's already changing science. 🧪

From breakthroughs like AlphaFold to advances in longevity research, we're beginning to see what happens when powerful AI tools are applied to complex biological problems. 🚀

The real question is: if AI can help unlock protein structures and accelerate longevity science, what else could it help us solve? 🤔

At NIOME, we apply the same principle to drug discovery, helping researchers test drug responses using scalable synthetic human genomes without the privacy and ethical limitations of real patient data. 🧬

Check out this week's episode featuring Dr. Johann Malawana as we explore how longevity research is revealing the true potential of AI.
Spotify: https://t.co/BAF9LuUZdG
Youtube: https://t.co/hAU9wN2HJH
Amazon: https://t.co/k2AyRpAZpz
Apple: https://t.co/p0029yKvB4

[Openτensor Foundaτion @opentensor]

Access to intelligence should not depend on a handful of companies or governments.

This is why open, decentralized, permissionless AI matters.

This is why Bittensor matters.

[Barry Silbert @BarrySilbert]

Unstoppable, uncensorable, global decentralized AI seems like a good investment bet to make. The “Bitcoin of AI” so to say…

[NIOME @NiomeAI]

https://t.co/EgifCMxhk3

[NIOME @NiomeAI]

When Alexander Fleming spotted penicillin growing in a petri dish, he unlocked a new era of healthcare. 🧫

Nearly a century later, the same spirit of curiosity drives innovation forward. 🔬

At NIOME, we’re helping researchers explore tomorrow’s breakthroughs with scientifically accurate synthetic genomes, because the next big discovery might start with a single observation.🧬

[NIOME @NiomeAI]

New Episode of 'Pulse'🎙️
The Role of AI in Human Longevity

AI isn't the first technology to transform healthcare. ❤️‍🩹

Google changed how patients access information about their conditions, reshaping the relationship between patients and clinicians. 📱

Now AI is accelerating that shift at a pace we've never seen before. 🚀

At NIOME, we are helping to accelerate scientific research through the simulation of synthetic human genomes, providing safe, accurate and scalable data that can be tailored to your research needs, without the privacy risks or ethical limitations associated with real patient data. 🧬

Check out this week's episode featuring Dr. Johann Malawana from The Healthcare Leadership Academy, as we discuss why AI is rapidly becoming a game changer for healthcare and human longevity.
Spotify: https://t.co/BAF9LuUZdG
Youtube: https://t.co/hAU9wN2HJH
Amazon: https://t.co/k2AyRpAZpz
Apple: https://t.co/p0029yKvB4

[NIOME @NiomeAI]

Join us to explore the highlights and success of our event and experience how AI is transforming innovation across the life sciences. 🧬

Discover new ideas, real-world impact, and what’s next for NIOME.🚀

https://t.co/EgifCMxhk3

[NIOME @NiomeAI]

We’ve reached a key milestone in the CFTR gene challenge — 129 validated samples.🧬

Each validated sample represents meaningful progress, and seeing the numbers climb like this adds real momentum to the effort of understanding Cystic Fibrosis.🔬

Follow along as it develops. This is only the beginning.🚀

A NIOME future is now! Join us! 💪

[NIOME @NiomeAI]

Bacteria have been on Earth for over 3.5 billion years, making them some of the oldest and most successful life forms ever to exist.🦠

They are the foundation of modern biological research, helping us understand genetics, evolution, disease, and antibiotic resistance.🧫

For NIOME  they represent a vast source of biological data that can power breakthroughs in healthcare, biotech, and decentralized scientific intelligence.🧬

Learn more here!

[NIOME @NiomeAI]

New Episode of 'Pulse' 🎙️
Can AI Prevent a Mental Health Crisis Before It Begins?

For some people, AI may be the first step toward seeking support without the fear of judgment or stigma. ⚠️

What if the real ethical question isn't whether AI should help, but what happens when no help is available at all? 🤔

Yet when AI starts to feel human, where should we draw the line between assistance and therapy? ✏️___

Check out this week's episode featuring Emmanuel Stiels, CEO of Reinhart, as we explore the ethical challenges and opportunities of AI in mental healthcare.
Spotify: https://t.co/aMvHiV3VVW
Youtube: https://t.co/PC3TV0KL5a
Amazon: https://t.co/k2AyRpAZpz
Apple: https://t.co/GN53hQqVyF

[NIOME @NiomeAI]

Before antibiotics, even minor bacterial infections could be fatal. 🦠

These life-saving medicines have transformed modern healthcare and saved millions of lives worldwide. 🌎

Yet the discovery of new antibiotics is slowing, while antibiotic-resistant bacteria continue to rise. ⚠️

Developing a new treatment can take more than a decade and cost hundreds of millions of dollars. 💊

At NIOME, we can help accelerate your research through scalable synthetic human genomes, allowing you to evaluate potential side effects early on and focus resources on the most promising treatments, without the privacy risk or ethical concerns of using real patient data. 🧬

Explore today's poster to learn more about antibiotics or check out NIOME here: https://t.co/Vmho9gxN1T

[NIOME @NiomeAI]

We have had quite a week bringing together the NIOME Summit 🧬

A big thank you to all who attended! Here a quick impression for those who missed it 🎥

Lots more to report next week!

A NIOME future is now! Join us. 🚀

[Lamida @LamidaGlobal]

Get out of $ZEC and buy $TAO

thank me in 2028.

[NIOME @NiomeAI]

Programmable cells are engineered living cells designed to sense biological signals and perform specific functions within the body. 🛠️

But before these therapies can reach patients, they must undergo rigorous testing. That's where NIOME comes in. 🧪

We can support this process by simulating scalable synthetic human genomes with realistic genetic variants. 🧬

This gives you access to high-quality data for studying treatment response and adverse effects without compromising privacy or ethics. 🚀

Learn more about programmable cells in today's poster or explore NIOME here: https://t.co/Vmho9gxN1T